Potential Role for Human Colony-Stimulating Factors in the Treatment of Radiation Injuries

  • William P. Peters


Hematopoiesis in humans appears to be controlled by a series of growth factors that are responsible for accelerating the proliferation and lineage-specific differentiation of committed progenitors. More than 10 factors acting at different and overlapping steps of hematopoietic differentiation have now been identified, molecularly cloned, expressed in vitro, and, in some cases, evaluated in primates and in the clinical setting. Because it has been shown clinically that growth factors can enhance hematopoietic reconstitution in patients with severe bone marrow injury, these factors have potential for treating radiation injury. This review explores the biological and biochemical as well as the clinical aspects of the colony-stimulating factors (CSF’s) currently in clinical use, particularly in relation to the treatment of nuclear accident injuries.


Radiation Injury Hematopoietic Reconstitution Granulocyte Transfusion Commit Progenitor Recombinant Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • William P. Peters
    • 1
  1. 1.Bone Marrow Transplant Program, Division of Hematology/Oncology, Department of MedicineDuke University Medical CenterDurhamUSA

Personalised recommendations